speb/financial-data huggingface dataset:
CSIQ income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -3223000.00
CSIQ balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -196379000.00
CSIQ income_statement (annual, 2024-12-31) — General And Administrative Expense: 515204000.00
CSIQ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 31026000.00
CSIQ balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1194913000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 1194913000.00
CSIQ balance_sheet (annual, 2024-12-31) — Gross PPE: 6908450000.00
CSIQ income_statement (annual, 2024-12-31) — Gross Profit: 999319000.00
CSIQ balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 14025000.00
CSIQ cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 113911000.00
CSIQ income_statement (annual, 2024-12-31) — Interest Expense: 137468000.00
CSIQ income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 137468000.00
CSIQ income_statement (annual, 2024-12-31) — Interest Income: 88470000.00
CSIQ income_statement (annual, 2024-12-31) — Interest Income Non Operating: 88470000.00
CSIQ cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 130964000.00
CSIQ balance_sheet (annual, 2024-12-31) — Inventory: 1206595000.00
CSIQ balance_sheet (annual, 2024-12-31) — Invested Capital: 8433320000.00
CSIQ cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1962257000.00
CSIQ balance_sheet (annual, 2024-12-31) — Investments And Advances: 232980000.00
CSIQ cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 482244000.00
CSIQ cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -14756000.00
CSIQ cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3280657000.00
CSIQ balance_sheet (annual, 2024-12-31) — Land And Improvements: 56234000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 56234000.00
CSIQ balance_sheet (annual, 2024-12-31) — Leases: 188780000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Leases: 188780000.00
CSIQ balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 271849000.00
CSIQ balance_sheet (annual, 2024-12-31) — Long Term Debt: 2878085000.00
CSIQ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3149934000.00
CSIQ cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1505811000.00
CSIQ cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -72211000.00
CSIQ balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 232980000.00
CSIQ balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2705009000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2705009000.00
CSIQ balance_sheet (annual, 2024-12-31) — Minority Interest: 1334303000.00
CSIQ income_statement (annual, 2024-12-31) — Minority Interests: 113913000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -39728000.00
CSIQ balance_sheet (annual, 2024-12-31) — Net Debt: 3916333000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income: 36051000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 36051000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -77862000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 36051000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 36051000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -77862000.00
CSIQ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -77862000.00
CSIQ income_statement (annual, 2024-12-31) — Net Interest Income: -48998000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -64650000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1657637000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 1433600000.00
CSIQ income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -48998000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 179890000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 12532000.00
CSIQ balance_sheet (annual, 2024-12-31) — Net PPE: 5530130000.00
CSIQ cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1870411000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 482244000.00
CSIQ cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: -14756000.00
CSIQ cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 224037000.00
CSIQ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2784474000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 75215000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 473500000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 204832000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 473500000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 204832000.00
CSIQ balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 118124000.00
CSIQ income_statement (annual, 2024-12-31) — Normalized EBITDA: 559832000.00
CSIQ income_statement (annual, 2024-12-31) — Normalized Income: 38629400.00
CSIQ cash_flow (annual, 2024-12-31) — Operating Cash Flow: -885324000.00
CSIQ cash_flow (annual, 2024-12-31) — Operating Gains Losses: 64126000.00
CSIQ income_statement (annual, 2024-12-31) — Operating Income: -30081000.00
CSIQ income_statement (annual, 2024-12-31) — Operating Revenue: 5993409000.00
CSIQ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 66954634.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Current Assets: 831011000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 2102223000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 402198000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -196379000.00
CSIQ income_statement (annual, 2024-12-31) — Other Gand A: 515204000.00
CSIQ income_statement (annual, 2024-12-31) — Other Income Expense: -3223000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 31026000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 31026000.00
CSIQ cash_flow (annual, 2024-12-31) — Other Non Cash Items: 44415000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1133498000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 588071000.00
CSIQ income_statement (annual, 2024-12-31) — Other Operating Expenses: -94543000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Payable: 984023000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Properties: 1648937000.00
CSIQ balance_sheet (annual, 2024-12-31) — Other Receivables: 142603000.00
CSIQ balance_sheet (annual, 2024-12-31) — Payables: 2050824000.00
CSIQ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2050824000.00
CSIQ cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 482244000.00
CSIQ cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: -14756000.00
CSIQ balance_sheet (annual, 2024-12-31) — Prepaid Assets: 124440000.00
CSIQ income_statement (annual, 2024-12-31) — Pretax Income: -82302000.00
CSIQ balance_sheet (annual, 2024-12-31) — Properties: 0.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CSIQ cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 39060000.00
CSIQ cash_flow (annual, 2024-12-31) — Purchase Of Business: -39728000.00
CSIQ cash_flow (annual, 2024-12-31) — Purchase Of Investment: -64650000.00
CSIQ cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1870411000.00
CSIQ balance_sheet (annual, 2024-12-31) — Raw Materials: 233034000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Raw Materials: 233034000.00
CSIQ balance_sheet (annual, 2024-12-31) — Receivables: 1488132000.00
CSIQ income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4994090000.00
CSIQ income_statement (annual, 2024-12-31) — Reconciled Depreciation: 501443000.00
CSIQ cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1623020000.00
CSIQ income_statement (annual, 2024-12-31) — Research And Development: 120792000.00
CSIQ balance_sheet (annual, 2024-12-31) — Restricted Cash: 551387000.00
CSIQ balance_sheet (annual, 2024-12-31) — Retained Earnings: 1585758000.00
CSIQ cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CSIQ income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 487947000.00
CSIQ income_statement (annual, 2024-12-31) — Selling General And Administration: 1003151000.00
CSIQ balance_sheet (annual, 2024-12-31) — Share Issued: 66954634.00
CSIQ cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 1774846000.00
CSIQ cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -1550809000.00
CSIQ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 21404000.00
CSIQ balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2815500000.00
CSIQ balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2784474000.00
CSIQ income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -644600.00
CSIQ income_statement (annual, 2024-12-31) — Tax Provision: -16576000.00
CSIQ income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.20
CSIQ balance_sheet (annual, 2024-12-31) — Taxes Receivable: 221539000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Assets: 13511550000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Capitalization: 5693585000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Debt: 5910996000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4149803000.00
CSIQ income_statement (annual, 2024-12-31) — Total Expenses: 6023490000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 9361747000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7594473000.00
CSIQ balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3942837000.00
CSIQ income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -30081000.00
CSIQ income_statement (annual, 2024-12-31) — Total Unusual Items: -3223000.00
CSIQ income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3223000.00
CSIQ balance_sheet (annual, 2024-12-31) — Work In Process: 157290000.00
CSIQ balance_sheet (quarterly, 2024-12-31) — Work In Process: 157290000.00
CSIQ balance_sheet (annual, 2024-12-31) — Working Capital: 498167000.00
CSIQ income_statement (quarterly, 2025-03-31) — +Operating Expense: 195299000.00
CSIQ income_statement (quarterly, 2025-03-31) — +Total Revenue: 1196625000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1033669000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 919858000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 581717000.00
CSIQ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 66962686.00
CSIQ income_statement (quarterly, 2025-03-31) — Basic EPS: -0.69
CSIQ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2264021000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -385087000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 341098000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1577275000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1577275000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 544238000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -468984000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -264203000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -349319000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Changes In Cash: -188949000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Common Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2769189000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -21404000.00
CSIQ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1056131000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Assets: 5990322000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 24222000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Debt: 2923228000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2947450000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 191385000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 191385000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5585610000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 573380000.00
CSIQ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 66962686.00
CSIQ income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.69
CSIQ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -33971000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 5686000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Non Current: 76640000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 934000.00
CSIQ income_statement (quarterly, 2025-03-31) — EBIT: -55244000.00
CSIQ income_statement (quarterly, 2025-03-31) — EBITDA: -55244000.00
CSIQ income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -4045000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -41153000.00
CSIQ cash_flow (quarterly, 2025-03-31) — End Cash Position: 2033919000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 544238000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -649290000.00
CSIQ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -12535000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -199858000.00
CSIQ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 105651000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 32903000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5838839000.00
CSIQ income_statement (quarterly, 2025-03-31) — Gross Profit: 140494000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 1406000.00
CSIQ income_statement (quarterly, 2025-03-31) — Interest Expense: 40487000.00
CSIQ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 40487000.00
CSIQ income_statement (quarterly, 2025-03-31) — Interest Income: 12096000.00
CSIQ income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 12096000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Inventory: 1498853000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8913868000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -468984000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 245668000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CSIQ cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 43896000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 316876000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3221451000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3538327000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 43896000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 245668000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1301462000.00
CSIQ income_statement (quarterly, 2025-03-31) — Minority Interests: 42683000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -21404000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Net Debt: 4567404000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income: -33971000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -33971000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -76654000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -33971000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -33971000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -76654000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -76654000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Interest Income: -28391000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 43896000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 43896000.00
CSIQ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -28391000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 521746000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -83897000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Net PPE: 5838839000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -385087000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2736286000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 76640000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 413961000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 118930000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 413961000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 118930000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 96757000.00
CSIQ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -42709000.00
CSIQ income_statement (quarterly, 2025-03-31) — Normalized Income: -24463590.54
CSIQ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -264203000.00
CSIQ income_statement (quarterly, 2025-03-31) — Operating Income: -54805000.00
CSIQ income_statement (quarterly, 2025-03-31) — Operating Revenue: 1196625000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 66954634.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 953307000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 2349848000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 482515000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -199858000.00
CSIQ income_statement (quarterly, 2025-03-31) — Other Gand A: 105651000.00
CSIQ income_statement (quarterly, 2025-03-31) — Other Income Expense: -12535000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 161770000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1200448000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 582020000.00
CSIQ income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -25403000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Payable: 929657000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Properties: 5838839000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Other Receivables: 164899000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Payables: 1964260000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1964260000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 186749000.00
CSIQ income_statement (quarterly, 2025-03-31) — Pretax Income: -95731000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -385087000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Receivables: 1335845000.00
CSIQ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1056131000.00
CSIQ cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -21404000.00
CSIQ income_statement (quarterly, 2025-03-31) — Research And Development: 24284000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 436887000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1551787000.00
CSIQ income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 90767000.00
CSIQ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 196418000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Share Issued: 66954634.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2769189000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2736286000.00
CSIQ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -3027590.54
CSIQ income_statement (quarterly, 2025-03-31) — Tax Provision: -23122000.00
CSIQ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CSIQ balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 245402000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Assets: 13895538000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5990640000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Debt: 6485777000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4070651000.00
CSIQ income_statement (quarterly, 2025-03-31) — Total Expenses: 1251430000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 9824887000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7905216000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4239277000.00
CSIQ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -54805000.00
CSIQ income_statement (quarterly, 2025-03-31) — Total Unusual Items: -12535000.00
CSIQ income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12535000.00
CSIQ balance_sheet (quarterly, 2025-03-31) — Working Capital: 404712000.00
CSIQ income_statement (quarterly, 2025-06-30) — +Operating Expense: 377597000.00
CSIQ income_statement (quarterly, 2025-06-30) — +Total Revenue: 1693871000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1016152000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 915302000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 575449000.00
CSIQ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 67167296.00
CSIQ income_statement (quarterly, 2025-06-30) — Basic EPS: 0.08
CSIQ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2033919000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -392424000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 346282000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1856034000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1856034000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 471055000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -448306000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 188556000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -222298000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Changes In Cash: 211305000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Common Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2854801000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -24221000.00
CSIQ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1188841000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Assets: 6209613000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 24972000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Debt: 2885499000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2910471000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 143224000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 143224000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5675562000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 610288000.00
CSIQ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 67167296.00
CSIQ income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.08
CSIQ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7197000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 2874000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Non Current: 78150000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 3427000.00
CSIQ income_statement (quarterly, 2025-06-30) — EBIT: 125941000.00
CSIQ income_statement (quarterly, 2025-06-30) — EBITDA: 125941000.00
CSIQ income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: -2053000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 18985000.00
CSIQ cash_flow (quarterly, 2025-06-30) — End Cash Position: 2264209000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 471055000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -203868000.00
CSIQ income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -11412000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -115175000.00
CSIQ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 252671000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 32212000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5719142000.00
CSIQ income_statement (quarterly, 2025-06-30) — Gross Profit: 505030000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 10936000.00
CSIQ income_statement (quarterly, 2025-06-30) — Interest Expense: 44807000.00
CSIQ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 44807000.00
CSIQ income_statement (quarterly, 2025-06-30) — Interest Income: 9920000.00
CSIQ income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 9920000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Inventory: 1247923000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9633838000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -448306000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 262015000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 321310000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3893538000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4214848000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 262015000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1321059000.00
CSIQ income_statement (quarterly, 2025-06-30) — Minority Interests: -37573000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -24221000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Net Debt: 4923003000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income: 7197000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7197000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 44770000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7197000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7197000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 44770000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 44770000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Interest Income: -34887000.00
CSIQ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -34887000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 495276000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -55882000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Net PPE: 5719142000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -392424000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2822589000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 78150000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 397146000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 119790000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 397146000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 119790000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 97985000.00
CSIQ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 137353000.00
CSIQ income_statement (quarterly, 2025-06-30) — Normalized Income: 16212480.00
CSIQ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 188556000.00
CSIQ income_statement (quarterly, 2025-06-30) — Operating Income: 127433000.00
CSIQ income_statement (quarterly, 2025-06-30) — Operating Revenue: 1693871000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 66954634.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1167608000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2275211000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 561499000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -115175000.00
CSIQ income_statement (quarterly, 2025-06-30) — Other Gand A: 252671000.00
CSIQ income_statement (quarterly, 2025-06-30) — Other Income Expense: -11412000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 32212000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 366084000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2015668000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 625871000.00
CSIQ income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -9272000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Payable: 1040789000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Properties: 5719142000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Other Receivables: 176542000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Payables: 2060368000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2060368000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 211625000.00
CSIQ income_statement (quarterly, 2025-06-30) — Pretax Income: 81134000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -392424000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Receivables: 1327462000.00
CSIQ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1188841000.00
CSIQ cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -24221000.00
CSIQ income_statement (quarterly, 2025-06-30) — Research And Development: 24719000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 388025000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1558984000.00
CSIQ income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 109479000.00
CSIQ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 362150000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Share Issued: 66954634.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2854801000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2822589000.00
CSIQ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -2396520.00
CSIQ income_statement (quarterly, 2025-06-30) — Tax Provision: 34311000.00
CSIQ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CSIQ balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 232744000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Assets: 14811931000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6748339000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Debt: 7125319000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4175860000.00
CSIQ income_statement (quarterly, 2025-06-30) — Total Expenses: 1566438000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 10636071000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8602318000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4960509000.00
CSIQ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 127433000.00
CSIQ income_statement (quarterly, 2025-06-30) — Total Unusual Items: -11412000.00
CSIQ income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -11412000.00
CSIQ balance_sheet (quarterly, 2025-06-30) — Working Capital: 534051000.00
CSIQ income_statement (quarterly, 2025-09-30) — +Operating Expense: 221712000.00
CSIQ income_statement (quarterly, 2025-09-30) — +Total Revenue: 1487402000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1070135000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 814685000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 579551000.00
CSIQ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 67620463.00
CSIQ income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
CSIQ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2264209000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -294453000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 370553000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1763311000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1763311000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 310411000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -287664000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -112060000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -304274000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Changes In Cash: -89313000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Common Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2868253000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CSIQ income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1231101000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Assets: 6385463000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 25889000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Debt: 3299005000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3324894000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 221652000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 221652000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5968174000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 745794000.00
CSIQ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 67620463.00
CSIQ income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
CSIQ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -25620000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 5723000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Non Current: 76813000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 2163000.00
CSIQ income_statement (quarterly, 2025-09-30) — EBIT: 36798000.00
CSIQ income_statement (quarterly, 2025-09-30) — EBITDA: 36798000.00
CSIQ income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: -6324000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 5035000.00
CSIQ cash_flow (quarterly, 2025-09-30) — End Cash Position: 2179931000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 310411000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -406513000.00
CSIQ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -12869000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -114811000.00
CSIQ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 116539000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 31987000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5788841000.00
CSIQ income_statement (quarterly, 2025-09-30) — Gross Profit: 256301000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 3570000.00
CSIQ income_statement (quarterly, 2025-09-30) — Interest Expense: 44414000.00
CSIQ income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44414000.00
CSIQ income_statement (quarterly, 2025-09-30) — Interest Income: 15078000.00
CSIQ income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 15078000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Inventory: 1244397000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9896711000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -287664000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 276083000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 344664000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3729453000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4074117000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 276083000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1490852000.00
CSIQ income_statement (quarterly, 2025-09-30) — Minority Interests: 30064000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Net Debt: 5265147000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income: 8986000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -25620000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -21078000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 8986000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 8986000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -21078000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -21078000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Interest Income: -29336000.00
CSIQ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -29336000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 310411000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 6789000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Net PPE: 5788841000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -294453000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2836266000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 76813000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 388129000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 117351000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 388129000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 117351000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 146046000.00
CSIQ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 49667000.00
CSIQ income_statement (quarterly, 2025-09-30) — Normalized Income: 19152510.00
CSIQ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -112060000.00
CSIQ income_statement (quarterly, 2025-09-30) — Operating Income: 34589000.00
CSIQ income_statement (quarterly, 2025-09-30) — Operating Revenue: 1487402000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 66954634.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1468888000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 2553211000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 452348000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -114811000.00
CSIQ income_statement (quarterly, 2025-09-30) — Other Gand A: 116539000.00
CSIQ income_statement (quarterly, 2025-09-30) — Other Income Expense: -12869000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 31987000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 213292000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2063638000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 638253000.00
CSIQ income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -16124000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Payable: 896982000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Properties: 5788841000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Other Receivables: 234915000.00
CSIQ income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 34606000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Payables: 1969280000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1969280000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 190491000.00
CSIQ income_statement (quarterly, 2025-09-30) — Pretax Income: -7616000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -294453000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Receivables: 1309057000.00
CSIQ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1231101000.00
CSIQ cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CSIQ income_statement (quarterly, 2025-09-30) — Research And Development: 19999000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 405749000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1567970000.00
CSIQ income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 101298000.00
CSIQ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 217837000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Share Issued: 66954634.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2868253000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2836266000.00
CSIQ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -2702490.00
CSIQ income_statement (quarterly, 2025-09-30) — Tax Provision: 7138000.00
CSIQ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CSIQ balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 253734000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Assets: 15157000000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6597706000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Debt: 7399011000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4359105000.00
CSIQ income_statement (quarterly, 2025-09-30) — Total Expenses: 1452813000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 10797895000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8771537000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4829721000.00
CSIQ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 34589000.00
CSIQ income_statement (quarterly, 2025-09-30) — Total Unusual Items: -12869000.00
CSIQ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -12869000.00
CSIQ balance_sheet (quarterly, 2025-09-30) — Working Capital: 417289000.00
CSIQ income_statement (annual, 2025-12-31) — +Operating Expense: 983070000.00
CSIQ income_statement (quarterly, 2025-12-31) — +Operating Expense: 188462000.00
CSIQ income_statement (annual, 2025-12-31) — +Total Revenue: 5595107000.00
CSIQ income_statement (quarterly, 2025-12-31) — +Total Revenue: 1217209000.00
CSIQ balance_sheet (annual, 2025-12-31) — Accounts Payable: 878827000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 878827000.00
CSIQ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 829957000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 829957000.00
CSIQ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1865661000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1865661000.00
CSIQ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 568921000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 568921000.00
CSIQ balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -82345000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -82345000.00
CSIQ cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 199336000.00
CSIQ income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
CSIQ income_statement (annual, 2025-12-31) — Basic Average Shares: 67368537.00
CSIQ income_statement (quarterly, 2025-12-31) — Basic Average Shares: 67712693.00
CSIQ income_statement (annual, 2025-12-31) — Basic EPS: -2.50
CSIQ income_statement (quarterly, 2025-12-31) — Basic EPS: -1.66
CSIQ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2264021000.00
CSIQ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2179931000.00
CSIQ balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 981598000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 981598000.00
CSIQ cash_flow (annual, 2025-12-31) — Capital Expenditure: -1391446000.00
CSIQ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -319482000.00
CSIQ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 381291000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 381291000.00
CSIQ balance_sheet (annual, 2025-12-31) — Capital Stock: 835543000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 835543000.00
CSIQ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1370418000.00
CSIQ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1370418000.00
CSIQ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1370418000.00